Table 3 Comparison between the control group and different cytogenetic risk groups regarding BECN1 gene expression
From: Reductive regulation of BECN1 gene in adult Egyptian patients with do novo AML
Control group | Cytogenetic risk group | P value | Sig. | ||||
Favourable | Intermediate | Adverse | |||||
BECN1 Median (IQR) | 1.12 (0.93–1.26) | 1.04 (1.03–1.07) | 0.44 (0.29–0.58) | 0.34 (0.27–0.51) | 0.000 | HS | |
Post hoc analysis | |||||||
Control vs favourable | Control vs intermediate | Control vs adverse | Favourable vs intermediate | Favourable vs adverse | Intermediate vs adverse | ||
BECN1 | 0.052 | 0.000 | 0.000 | 0.008 | 0.000 | 0.469 | |